Write in a clean editor, then format for Cell Reports Medicine in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Cell Reports Medicine is a peer-reviewed journal published by Elsevier, covering Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, CAR-T cell therapy research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Cell Reports Medicine 12 (2023) 45–58.
Formats any DOI in Cell Reports Medicine style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction CAR-T cell therapy research SARS-CoV-2 and COVID-19 Research Immunotherapy and Immune Responses |
| ISSN | 2666-3791 |
| Citation impact (2-yr) | 11.22 |
| h-index | 102 |
| i10-index | 1,172 |
| Total citations | 56,400 |
| Article processing charge | $5,460 |
| Open access | Yes |
| Top institutions publishing here | Sun Yat-sen University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
T cell epitopes, respectively, are affected by mutations in the various VOCs. Thus, the SARS-CoV-2 variants analyzed here do not significantly disrupt the total SARS-CoV-2 T cell reactivity; however, the decreases observed highlight the importance for active monitoring of T cell reactivity in the context of SARS-CoV-2 evolution.
SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We report a cross-sectional study of antibody responses to the receptor-binding domain (RBD) of the spike protein and virus neutralization activity in…
SARS-CoV-2 has recently been detected in feces, which indicates that wastewater may be used to monitor viral prevalence in the community. Here, we use RT-qPCR to monitor wastewater for SARS-CoV-2 RNA over a 74-day time course. We show that changes in SARS-CoV-2 RNA concentrations follow symptom onset gathered by retrospective interview of patients but precedes…
Monoclonal antibodies and antibody cocktails are a promising therapeutic and prophylaxis for coronavirus disease 2019 (COVID-19). However, ongoing evolution of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can render monoclonal antibodies ineffective. Here, we completely map all of the mutations to the SARS-CoV-2 spike receptor-binding domain (RBD) that escape binding by a leading monoclonal antibody, LY-CoV555, and…
